L. Belec et al., DECREASED CERVICOVAGINAL PRODUCTION OF BOTH IGA1 AND IGA2 SUBCLASSES IN WOMEN WITH AIDS, Clinical and experimental immunology, 101(1), 1995, pp. 100-106
Paired sera and cervicovaginal secretions from 35 HIV-1-infected women
representing different CDC stages of HIV infection were evaluated for
total IgA, IgA1 and IgA2, for IgA, IgA1 and IgA2 to gp160, and for al
bumin. Age-matched healthy women (n = 45) served as controls. The secr
etion rates of total IgA, IgA1 and IgA2 were evaluated by calculating
their relative coefficients of excretion by reference to albumin. In H
IV-infected women, total IgA1 and IgA2 in sera and in cervicovaginal s
ecretions increased proportionately as early as stages II + III and mo
re markedly at stage IV. By contrast, the secretion rates of total IgA
, IgA1 and IgA2 were markedly reduced in AIDS women, the IgA2 secretio
n rate decreasing significantly as early as stages II + III. This appa
rent discrepancy was probably the result of increased transudation of
serum-borne immunoglobulins into the vaginal cavity, since albumin lev
els in cervicovaginal secretions increased significantly according to
the stages of disease. HIV-reactive IgA antibodies in serum, as in cer
vicovaginal secretions, were principally found within the IgA1 subclas
s. In women at stage IV, a high local production of IgA1 to gp160 occu
rred in spite of the impairment of cervicovaginal IgA synthesis, proba
bly because of marked genital HIV replication at advanced stages,